Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Pulmonary Medicine|January 2, 2024
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary diseaseChee Hong Loh, Jill A Ohar
Annals of the Academy of Medicine, Singapore|August 13, 2025
Chronic obstructive pulmonary disease 30-day readmission metric: Risk adjustment for multimorbidity and frailtyAnthony Yii, Isaac Fong, Sean Chee Hong Loh, et al.
Respirology Case Reports|October 20, 2021
Idiopathic recurrent serositis-Off the beaten trackMelanie Trishna Hui Min Roy, Chee Hong Loh, Melonie Sriranganathan, et al.
BMJ Open|September 1, 2023
Year-to-year trajectories of hospital utilisation rates among patients with COPD: a real-world, single-centre, retrospective cohort studyAnthony Yii, Xiaomeng Xu, Chee Hong Loh, et al.
Journal of Thoracic Disease|March 20, 2024
A comparison of GOLD 2019 and 2023 recommendations to contemporaneous real-world inhaler treatment patterns for chronic obstructive pulmonary disease management in SingaporeRayan Alsuwaigh, Anthony Yii, Chee Hong Loh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|June 17, 2022
Characteristics of Patients with Chronic Obstructive Pulmonary Disease Treated with Long-Acting Bronchodilators in a Real-World Setting in Singapore: A Single-Center Observational StudyMarcus Sim, Anthony Yii, Xiaomeng Xu, et al.
Singapore Medical Journal|April 3, 2022
Characteristics of Singapore lung cancer patients who miss out on lung cancer screening recommendationsChee Hong Loh, Pearly Wenjia Koh, Daniel Jia Ming Ang, et al.
Annals of the Academy of Medicine, Singapore|November 26, 2020
Point-of-Care Ultrasound Training Among Intensivists in Singapore: A Multicentre SurveyYie Hui Lau, Chee Hong Loh, Wee Kim Fong, et al.
Singapore Medical Journal|March 16, 2021
A risk prediction score to identify patients at low risk for COVID-19 infectionWui Mei Chew, Chee Hong Loh, Aditi Jalali, et al.
Thorax|December 3, 2025
Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trialAnthony Yii, Tunn Ren Tay, Ken Cheah Hooi Lee, et al.
Pageof 2